Table 5. Summary of the results for normal control subjects and DE patients (medium + SD), data are expressed as percentage (%) versus total content and mg/ml sample.
| Analite |
% versus total protein content |
p |
mg/ml |
p | ||
|---|---|---|---|---|---|---|
| Normal subjects | DE patients | Normal subjects | DE patients | |||
| LYS-C |
34.96±6.78 |
34.92±9.49 |
0.09 |
3.06±1.08 |
2.15±0.78 |
<0.0001 |
| LACTO |
24.14±5.08 |
21.44±6.69 |
0.01 |
2.11±0.74 |
1.4±0.76 |
<0.0001 |
| LIPOC-1 |
18.26±4 |
15.27±6.03 |
0.0002 |
1.71±0.52 |
0.98±0.49 |
<0.0001 |
| TRANSF |
9.58±2.96 |
4.52±3.78 |
<0.0001 |
0.89±0.67 |
0.33±0.36 |
<0.0001 |
| ALB |
4.27±4 |
11.91±12.82 |
<0.0001 |
0.21±0.55 |
0.94±1.28 |
<0.0001 |
| ZAG-2 |
4.94±1.05 |
3.13±2.28 |
<0.0001 |
0.43±0.24 |
0.25±0.22 |
<0.0001 |
| Total Protein (TP) | 9.89±2.28 | 6.44±2.1 | <0.0001 | |||
Total Protein content is only expressed in absolute value mg/ml. A statistically significant decrease was demonstrated in all proteins, except albumin that showed a significant increase in DE patients versus controls.